PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PolyPeptide Group AG
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Change in Working Capital
€40.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Change in Working Capital
-CHf61.5m
CAGR 3-Years
-62%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Siegfried Holding AG
SIX:SFZN
Change in Working Capital
-CHf18.5m
CAGR 3-Years
N/A
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Change in Working Capital
-CHf248m
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
-10%
Tecan Group AG
SIX:TECN
Change in Working Capital
-CHf49.8m
CAGR 3-Years
-342%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Change in Working Capital
-CHf42.9m
CAGR 3-Years
-57%
CAGR 5-Years
-73%
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
921.9m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
24.99 CHF
Overvaluation 11%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Change in Working Capital?
Change in Working Capital
40.7m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Change in Working Capital amounts to 40.7m EUR.

Back to Top